Moderna Inc at Nasdaq Investor Conference (Virtual) Transcript
Great. Hello, everybody. Thanks for joining us for the next session. I'm Matthew Harrison, one of the biotech analysts here at Morgan Stanley. We're very pleased to have Moderna with us for this session.
Just some comments before we get started, I need to read a disclosure statement. For important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures.
Secondly, you can ask questions throughout the webcast if you would like. (Operator Instructions)
And then thirdly, so pleased to have both David Meline, the CFO from Moderna; and Paul Burton, the CMO. So we'll jump into it and looking forward to it.
Questions & Answers
So I guess Paul, maybe just to start out, we should probably address Omicron, and just what's Moderna's outlook on Omicron just from a virus standpoint itself? And what sort of level of evidence
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |